secwatch / observer
8-K filed June 27, 2023, 7:59 PM ET ticker ERAS CIK 0001761918
other material confidence high sentiment neutral materiality 0.10

Erasca shareholders elect three Class II directors, ratify KPMG as auditor at annual meeting

Erasca, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Erasca, Inc. shareholders approved Election of three Class II Directors for a term of three years expiring at the 2026 annual meeting of stockholders at the 2023-06-22 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-22
Exact text from the filing
Election of three Class II Directors for a term of three years expiring at the 2026 annual meeting of stockholders Alexander W. Casdin For 101,317,047 Withheld 8,205,892 Julie Hambleton, M.D. For 102,122,261 Withheld 7,400,678 Michael D. Varney, Ph.D. For 100,882,700 Withheld 8,640,239 There were 12,791,479 broker non-votes for this proposal. The three nominees for Class II Director were elected.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

Erasca, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-22 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-22
Exact text from the filing
Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 For 122,279,001 Withheld 3,124 Against 32,293 There were 0 broker non-votes for this proposal. The appointment of KPMG LLP was ratified.
View on SEC.gov

Browse all shareholder votes →

Erasca, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-030108
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.